Polymorphonuclear cells stimulate the migration and metastatic potential of rat sarcoma cells

International Journal of Experimental Pathology

Volumn 90, Issue 1, 2009, Pages 44-51

  Remedi, María Mónica ^a   Donadio, Ana Carolina ^a   Chiabrando, Gustavo Alberto ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Intercellular adhesion molecule 1; Metalloproteases; Metastasis; Neutrophils; Tumour; uPA receptor

Indexed keywords

GELATINASE A; INTERCELLULAR ADHESION MOLECULE 1; MATRIX METALLOPROTEINASE 14; UROKINASE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; METASTASIS; NEUTROPHIL; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SARCOMA; SARCOMA CELL; TUMOR GROWTH;

ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CULTURE MEDIA, CONDITIONED; FEMALE; INTERCELLULAR ADHESION MOLECULE-1; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEUTROPHILS; RATS; RATS, WISTAR; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SARCOMA, EXPERIMENTAL; WOUND HEALING;

EID: 58549119601     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2008.00628.x     Document Type: Article

References (35)

1. Alfano D., Franco P., Vocca I. et al. (2005) The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis. Thromb. Haemost. 93, 205 211.
2. Chen P.W., Uno T., Ksander B.R. (2006) Tumor escape mutants develop within an immune-privileged environment in the absence of T cell selection. J. Immunol. 177, 162 168.
3. Coussens L.M. (2002) Inflammation and cancer. Nature 420, 860 867.
4. Di Carlo E., Forni G., Lollini P., Colombo M.P., Modesti A., Musiani P. (2001) The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 97, 339 345.
5. Donadio A.C., Remedi M.M., Frede S., Bonacci G.R., Chiabrando G.A., Pistoresi-Palencia M.C. (2002) Decreased expression of intercellular adhesion molecule-1 (ICAM-1) and urokinase-type plasminogen activator receptor (uPAR) is associated with tumor cell spreading in vivo. Clin. Exp. Metastasis 19, 437 444.
6. Donadio A.C., Durand S., Remedi M.M. et al. (2005) Evaluation of stromal metalloproteinases and vascular endothelial growth factors in a spontaneous metastasis model. Exp. Mol. Pathol. 79, 259 264.
7. Egeblad M. Werb Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 3, 161 174.
8. Hotary K.B., Allen E.D., Brooks P.C., Datta N.S., Long M.W., Weiss S.J. (2003) Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114, 33 45.
9. Ishihara Y., Iijima H., Matsunaga K. (1998) Contribution of cytokines on the suppression of lung metastasis. Biotherapy 11, 267 275.
10. Iwatsuki K., Kumara E., Yoshimine T., Nakagawa H., Sato M., Havakawa T. (2000) Elastase expression by infiltrating neutrophils in gliomas. Neurol. Res. 22, 465 468.
11. Kenny H.A., Kaur S., Coussens L.M., Lengyel E. (2008) The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J. Clin. Invest. 118, 1367 1379.
12. Kugler M.C., Wei Y., Chapman H.A. (2003) Urokinase receptor and integrin interactions. Curr. Pharm. Des. 9, 1565 1574.
13. Kuper H., Adani H.O., Trichopoulos D. (2000) Infections as a major preventable cause of human cancer. Intern. Med. 248, 171 183.
14. Kurschat P., Zigrino P., Nischt R. et al. (1999) Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J. Biol. Chem. 274, 21056 21062.
15. Lin E.Y. Pollard J.W. (2004) Role of infiltrated leucocytes in tumor growth and spread. Br. J. Cancer 90, 2053 2058.
16. Liotta L.A. Kohn E.C. (2001) The microenvironment of the tumor-host interface. Nature 411, 375 379.
17. Lund T. Osterud B. (2004) The effect of TNF-alpha, PMA, and LPS on plasma and cell-associated IL-8 in human leukocytes. Thromb. Res. 113, 75 83.
18. Ma Z., Chang M.J., Shah R., Adamski J., Zhao X., Benveniste E.N. (2004) Brg-1 is required for maximal transcription of the human matrix metalloproteinase-2 gene. J. Biol. Chem. 279, 46326 46334.
19. Maruo Y., Gochi A., Kaihara A. et al. (2002) ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer. Int. J. Cancer 100, 486 490.
20. Mian B.M., Dinney C.P., Bermejo C.E. et al. (2003) Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. Clin. Cancer Res. 9, 3167 3175.
21. Morgan H. Hill P.A. (2005) Human breast cancer cell mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity. Cancer Cell Int. 5, 1.
22. Nguyen D.H., Webb D.J., Catling A.D. et al. (2000) Urokinase-type plasminogen activator stimulates the Ras/Extracellular signal-regulated kinase (ERK) signalling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, Src, and Shc. Rapid dissociation of GRB2/Sps-Shc complex is associated with the transient phosphorylation of ERK in urokinase-treated cells. J. Biol. Chem. 275, 19382 19388.
23. Pease J.E. Williams T.J. (2006) Chemokines and their receptors in allergic disease. J. Allergy Clin. Immunol. 118, 305 318.
24. Peng H.H., Liang S., Henderson A.J., Dong C. (2007) Regulation of interleukin-8 expression in melanoma-stimulated neutrophil inflammatory response. Exp. Cell Res. 313, 551 559.
25. Queen M.M., Ryan R.E., Holzer R.G., Keller-Peck C.R., Jorcyk C.L. (2005) Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res. 65, 8896 8904.
26. Ribatti D., Vacca A., Nico B., Crivellato E., Roncali L., Dammacco F. (2001) The role of mast cells in tumor angiogenesis. Br. J. Haematol. 115, 514 521.
27. Schaider H., Oka M., Bogenrieder T. et al. (2003) Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int. J. Cancer 103, 335 343.
28. Seiki M. Yana I. (2003) Roles of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Sci. 94, 569 574.
29. Shamamian P., Schwartz J.D., Pocock B.J. et al. (2001) Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J. Cell. Physiol. 189, 197 206.
30. Shi Q., Benderdour M., Lavigne P., Ranger P., Fernandes J.C. (2003) Evidence for two distinct pathways in TNFα-induced membrane and soluble forms of ICAM-1 in human osteoblast-like cells isolated from osteoarthritic patients. Osteoarthritis Cartilage 15, 300 308.
31. Sica A., Schioppa T., Mantovani A., Allavena P. (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717 727.
32. Sounni N.E., Janssen M., Foidart J.M., Noel A. (2003) Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis. Matrix Biol. 22, 55 61.
33. Starkey J.R., Liggitt H.D., Jones W., Hosick H.L. (1984) Influence of migratory blood cells on the attachment of tumor cells to vascular endothelium. Int. J. Cancer 34, 535 543.
34. Wang J.H., Sexton D.M., Redmond H.P., Watson R.W.G., Croke D.T., Bouchier-Hayes D. (1997) Intercellular adhesion molecule-1 (ICAM-1) is expressed on human neutrophils and is essential for neutrophil adherence and aggregation. Shock 8, 357 361.
35. Yasuda M., Tanaka Y., Tamura M. et al. (2001) Stimulation of beta1 integrin down-regulates ICAM-1 expression and ICAM-1-dependent adhesion of lung cancer cells through focal adhesion kinase. Cancer Res. 61, 2022 2030.